Home / Resource Library / Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma

Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

Comparative Toxicity and Survival Outcomes of LMB-96 Chemotherapy Protocol with or Without Rituximab in Pediatric High-Risk B-Cell Non-Hodgkin Lymphoma